Effects of Doxorubicin on Gene Expression in Liposarcoma
Author Information
Author(s): Adrien Daigeler, Ludger Klein-Hitpass, Michael Chromik Ansgar, Oliver Müller, Jörg Hauser, Heinz-Herbert Homann, Hans-Ulrich Steinau, Marcus Lehnhardt
Primary Institution: BG-University Hospital Bergmannsheil, Ruhr University Bochum
Hypothesis
This study aims to identify gene expression changes in liposarcoma after doxorubicin treatment.
Conclusion
The study found that high-grade liposarcomas showed more consistent gene expression changes in response to doxorubicin compared to low-grade tumors.
Supporting Evidence
- More than 50% of the samples showed up-regulation of pro-apoptotic genes.
- High-grade tumors had similar responses in selected apoptosis genes.
- Low-grade liposarcomas showed minimal changes in gene expression after treatment.
Takeaway
The study looked at how a cancer drug called doxorubicin affects the genes in liposarcoma cells, finding that some tumors respond better than others.
Methodology
Cells from 19 primary human liposarcoma tumors were cultured and treated with doxorubicin for 24 hours, followed by RNA isolation and microarray analysis.
Limitations
The study may be limited by the inter- and intra-tumoral heterogeneity of liposarcomas.
Participant Demographics
The study included 19 patients with various subtypes of liposarcoma, including atypical lipomas and dedifferentiated tumors.
Statistical Information
P-Value
<0.004
Statistical Significance
p<0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website